The pregnancy was complicated by a twin gestation with probable twin-twin transfusion evident by oligohydramnios in 1 twin and polyhydramnios in another twin.
The infant received bag-mask ventilation in the delivery room and Apgars were 7 at 1 minutes and 8 at 5 minutes.
Due to respiratory distress, the infant was endotracheally intubated and brought to the NICU for further care.
SUMMARY OF HOSPITAL COURSE BY SYSTEMS:  Respiratory: The infant was intubated in the delivery room and placed on SIMV.
Due to persistent desaturation on day of life #1, the infant was changed to a high frequency oscillator with a maximum mean airway pressure of 14.
Caffeine was started on day of life #5.
The infant remained in CPAP until day of life #11 when she was changed to nasal cannula.
The infant since that time has been receiving nasal cannula between 200 and 300 cc of 21%-30% FIO2.
Currently, the infant is on nasal cannula of 300 cc with an FIO2 ranging between 21% and 30%.
The infant continues with multiple spells, averaging about 10 times per day and is currently on caffeine with a current dose of caffeine citrate of 7.5 mg p.o.
Due to a birth weight of less than 1000 g, the infant was also treated with vitamin A to receive a total of 12 doses.
Feeds were initiated on day of life #7 with PE20 and slowly advanced to full feeds on day of life #15.
The infant also had hypochloremia and hyponatremia requiring sodium chloride supplementations.
These supplements were started on day of life #23.
A most recent set of electrolytes was day of life #24 with a sodium of 130, potassium 5.4, chloride 93, bicarbonate of 29.
The infant is also receiving ferrous sulfate 0.1 cc p.o.
PG and vitamin E 5 units p.o.
Lines: The infant had a double lumen UV as well as an umbilical arterial line placed initially and a PICC line following which was discontinued on day of life #15.
Due to the neutropenia, the infant was treated with 7 days of ampicillin and gentamicin.
When repeat hematocrit was 29%, the infant received a 2nd packed red blood cell transfusion on day of life [**1-8**].
GI: Phototherapy was started at 12 hours of age with a maximum bilirubin at that time of 6.4 and was discontinued on day of life #12.
Medications: Caffeine citrate 7.5 mg p.o.
daily, vitamin A 5000 units IM, ferrous sulfate 0.1 cc p.o.
PG, vitamin E 5 units p.o.
PG daily, sodium chloride 1.5 mEq p.o.
Immunizations Received: None.
Immunizations Recommended: Synergist RSV prophylaxis should be considered from [**Month (only) **] through [**Month (only) 958**] for infants who meet any of the following 3 criteria - i) born at less than 32 weeks; ii) born between 32 and 35 weeks with 2 of the following - day care during RSV season, a smoker in the household, neuromuscular disease, airway abnormalities or school age siblings; or iii) infants with chronic lung disease.
Influenza immunization is recommended annually in the fall for all infants once they reach 6 months of age.
Before this age (and for the first 24 months of the child's life), immunization against influenza is recommended for household contacts and out-of-home caregivers.
